The Present and Future of Radiotherapy

The radiotherapy market is growing due to several factors, such as an increase in the number of new cancer cases and technological advancement in the hardware and software used in radiotherapy. The current international markets are underequipped to address new cases of cancer. In low- and middle-income countries, only 10% of the population has access to radiotherapy. Therefore, there exists a wide gap between the demand and the installed base of equipment, which offers a huge opportunity for the companies to grow in the radiotherapy market. Expansion of the radiotherapy market can be both lifesaving and profitable.

Effective planning for the treatment

It is necessary, and continuous technological developments are taking place to minimize the exposure to radiation of healthy tissue, in order to avoid any side effect. This goal is a driving force of R&D for radiotherapy. Software plays an increasingly significant role in cancer care. Population growth and increased life expectancy are adding to the incidences of cancer. The software & services segment includes software, which is used for treatment planning, analysis, and services, which are needed for the maintenance and efficient use of radiotherapy devices. The software & services segment of the companies are expected to grow, as software products help improve physician engagement and clinical knowledge-sharing, patient care management, and the management of cancer clinics, radiotherapy centers, and oncology practices for better performance. Companies like Varian are continuously increasing their software portfolio. Software plays an increasingly significant role in cancer care. At the same time, healthcare systems are subject to harsh budgetary constraints in nearly every country. As a result, healthcare providers face the challenge of achieving more while using fewer resources. To achieve this goal, hospitals have a strong need for software platforms that make radiotherapy treatment cost-effective. The development of effective software will improve the delivery of advanced radiotherapy in the future.

Introduction of new technology
Technology is another salient feature. Radiation therapy remains a significant modality for cancer treatment, which is the primary driving factor for the designing of new techniques to improve the survival rate of cancer patients. New technologies, like proton beam therapy, are available in developed countries like the United States, Germany, and United Kingdom, due to well-established reimbursement policies. Proton therapy can be used on tissues that are highly sensitive, like brain, spine, and eye tumors. It is more accurate, as compared to other X-ray radiation therapies.

Advancement in the technology is also helping to execute the planning of the radiation therapy.

Technological advancement in existing technologies, such as CT imaging, is making imaging more accurate and consistent. This can give a better representation of a tumor and help in better planning. Already-existing technology, such as IMRT, SBRT, IGRT, conformal 3D, VMAT, and others that are used for radiation therapy treatment is undergoing various advancements. For example, Varian is developing a software, which can be used to develop better planning tools, in which statistical models can be used to calculate the quality of an IMRT treatment for a patient. This is expected to increase the usage of IMRT for treating cancer. IGRT is the type of radiotherapy. Research is more focused on IGRT, in order to prove its fewer side-effects. IGRT may include electronic portal imaging, fluoroscopy, ultrasound, CT scan reconstruction, and respiratory gating technology. SBRT is also growing as an option for treating cancer. SBRT is used to escalate the dose to the targeted tumor, which can increase local control while limiting the dose to nearby critical structures and normal tissues. This will cause minimum damage to the surrounding tissues and hence, will experience strong growth in the forecast period.

Environmental Factors for Hair Loss

ENVIRONMENTAL FACTORS OF HAIR LOSS

Hair loss – a common problem which adversely impacts the self-esteem of a number of individuals all over the world. While many people blame the condition entirely on genetics, it is important to know that there are many other factors which contribute to both female and male pattern baldness.

There are numerous individuals know about the way that our encompassing condition can assume a key part in causing male pattern baldness. The beneath specified focuses will tell about the different ecological elements which can prompt male pattern baldness in the two people:

1. Contamination

Debased air contains toxins and cancer-causing agents which can meddle with the protein in charge of hair development bringing about loss of hair. As per researchers, a few poisons can enter the circulatory system, body and skin, and debilitate the hair follicles. It is consequently that spots with a dirtied domain have more number of bare individuals.

2. Hard Water

Hard water is one of the greatest ecological components that prompt male pattern baldness. Late looks into have demonstrated that nations having water with more PPM (parts per million) have more number of uncovered individuals. Higher amounts of magnesium, calcium and silica can cause dryness and harm the hair.

3. Concoction Substances

Barely any compound substances, for example, chlorine found in swimming pools are known to mischief and harm the hair. While there’s nothing concrete over the immediate connection amongst chlorine and sparseness, it is regularly connected to adversely influencing the general prosperity of hair.

4. Warmth and Sun

Drawn out presentation to the sun may bring about perpetual male pattern baldness. A sunburn influencing the scalp can enact Telogen Effluvium, which is a male example hair sparseness condition wherein more than expected follicles enter the resting period of the development cycle. This can exacerbate the male pattern baldness issue.

ADVANTAGES OF HAIR TRANSPLANT

1. There are no complications in hair transplantation:- Hair transplants are very protected. In any case, it’s somewhat of an extend to state that they are without inconvenience. Patients may have redness, swelling and crusting post operatively. When all is said in done, the recuperation in FUE methodology is considerably less demanding than FUT strategies. In any case, there are uncommon difficulties in hair transplant surgery that incorporate dependable nerve torment (more in FUT than FUE systems) and steady scalp redness. Unless a doctor is painstakingly checking the methodology, a patient can even become ill. The hair transplant group tends to bashful far from calling hair transplant systems a ‘surgery’ to make the strategy more patient neighborly – yet don’t imagine it any other way a hair transplant is a surgery.

2. You will regain the hair density of your youth:- A hair transplant is a surgical system which included moving somewhere in the range of 10 to 10,000 hairs into a zone of thinning up top. On the off chance that a region of male pattern baldness is little, it might be conceivable to manufacture some extremely decent thickness in the territory – yet the thickness is for the most part short of what it used to be. For instance, in a patient who is exceptionally uncovered, a thickness of 35-40 follicular units for every square centimeter will regularly be made. This zone likely had a thickness of at least 90 follicular units for every square centimeter at one time years sooner. In this way, it is for the most part the standard for a hair transplant to make comes about that are less thick than the first thickness. A talented specialist can regularly help make 35-40 follicular units resemble the first thickness. Be that as it may, photographs and recordings of patients with incredibly thick and thick hair following their technique may not generally be exact.

Cardiac Diagnosis Support By Global Air Ambulance Services In Allahabad With Medical Faculty

We serve the Air Relocation Services that flies local and distant aircraft, across the counties in the world

Global Air Evacuation Services is expanding its services to fly patients over 5 counties. Our Charted Aircraft provide a rapid response to trauma and medical emergencies over several cities and countries covering many of India’s major road networks.

With an average response between them, our aircraft attend on average. Our Critical Care Cars then work throughout the night attending medical emergencies that occur within these regions creating a service that operates 24/7, 365 days a year.

If you’re local, you may well have seen us in the skies above you. What many people don’t realize when seeing our air ambulances or visiting our office is that we’re a least chargeable Air Ambulance Service provider, so we’re only able to continue with our services because of generous evacuation.

Here we are the best support of the Air Ambulance to shift the patients to the required and needed designation with the comfortable support of the medical equips to avail the treatments along the specialist faculty of the MD Doctors and the Emergency Medical Technicians to observe the patient all along the process of the medical tourism only with Global Air Ambulance Services.

We are here to facilitate all the citizens of India with the emergency rehabilitation support via airways, railways, and also with the Roadways ambulance services to shift the critical patients with the setup of the medical equipment’s and the medical faculty to treat the patients with the diagnosis all along the evacuation process.

The Global Air Ambulance in Allahabad is always at the top of the emergency services like medical team (a large and smart channel of MD doctors panel, a group of paramedical technicians, nursing staff and medical dispatches; they all are always ready) emergency Equipment such as ventilators, cardiac monitor, suction machine, infusion pump, nebulizer machine, oxygen cylinder, speed maker, defied Radiator, all basic and advance support), help and transfer serious patients round-the-clock. (Always in need of necessary updates and renewal costs which is very economical and reliable); Services (Patient Transfer Ground-Rail-Ground, Ground-Air-Ground, 24/7 Hours), Experience (Approximate Most Required) and provides the safe, experienced, responsible and quick emergency evacuation services necessary for patients.

We are also available with the Air Ambulance in Bangalore so the citizens of Bangalore could meet the needs of the emergency facility. One of the Super Specialty Emergency Service Providers, which will give them personal ambulance services, Commercial Airlines Stretcher Services (Air India, Jet Airways, Indigo, Go Air, Air Asia, Other), Train Medical Preservation Services and Road Ambulance (ACLS, BLS, BLS ) Offers and QEV) Expert, experienced and responsible medical care team to move serious people in less time under the unit.

The Life of Mammogram Inventor Stafford L Warren

Stafford L. Warren was one of the most significant contributors to radiology during his lifetime. He not only was the first doctor to perform a mammogram, but was also had a hand in turning UCLA into one of the most prestigious medical universities in the country, was a special assistant on mental disabilities to Presidents John F Kennedy and Lyndon B Johnson, and aided the U.S. government in testing of nuclear weapons before speaking out about the dangers of nuclear fallout from weapons testing, which were controversial at the time. However, his strong opinions would eventually be considered, leading up to the Partial Nuclear Test Ban Treaty in 1963.

Born in New Mexico in 1896, Stafford L. Warren attended the University of California, Berkeley, and graduated with his Bachelor of Arts degree in 1918. Heading to the University of California, San Francisco, he graduated with his Doctor of Medicine degree in 1922 and later did post-doctoral work at John Hopkins School of Medicine and Harvard University.

Warren became an Assistant Professor of Medicine at the University of Rochester School of Medicine in 1926. Since the Department of Radiology was brand new at the time, Warren was one of the original group of medical professionals that Dean George Whipple chose to staff the school. By 1930, Warren was an Associate Professor of Medicine. He began to study the work of Albert Salomon, a sociologist from the University of Berlin who produced over 3,000 images of mastectomy specimens and extensively studied the many forms and stages of cancer in the breast. Since Salomon wasn’t keen to recognize the life saving aspects of his discoveries, Warren expanded on his research, using radiology to track changes in breast tissue and developing a stereoscopic technique in which the patient would lie on her side with one arm raised while being X-Rayed. This was a huge breakthrough for breast cancer detection, as it allowed diagnosis of breast cancer to be possible without surgery. Warren subsequently published “A Roentgenologic Study of the Breast” in 1930. Today Warren is cited as the inventor of the mammogram for his breast imaging technique. Each year mammograms are responsible to diagnosing millions of breast cancer cases, effectively saving the lives of women the world over.

Warren, having now tackled a major milestone in his career and developing a new life saving technique, then went on to take on a new project: overseeing the health and safety of thousands during the Manhattan Project. His new role meant being responsible for the safety aspects of the detonation of the Trinity nuclear test in Alamogordo, New Mexico on July 16, 1945. He later handled radiological safety when he led a team of surveyors to Japan, and to the Bikini Atoll in 1946, where more nuclear testing was done. Warren was in charge of assessing the radioactive contamination of the environment and atmosphere, which he was appalled by.

In response to this, in a piece for LIFE magazine in 1947 he wrote, “The development of atomic bombs has presented the world with a variety of formidable scientific, moral and political problems, nearly all of them still unsolved.” He went on to write an in depth analysis of the effects of the bombs, people and environment affected, the time length in which the effects of the bomb lasted, safety measures used during the Bikini expedition in which “a month passed before men could stay on some of the ships for more than an hour”, and “300 men of the safety section lived and worked in the contaminated area to protect some 42,000 other members of the Bikini expedition. Every group which entered the target area was accompanied by a safety monitor who determined how long it could stay.” The men were then bathed carefully when they returned, and if their Geiger counters indicated radioactive contamination they had to be bathed again. “Occasionally when a man had taken off his protective gloves in the ‘hot’ area, the safety section had to dissolve the outer layer of skin from their hands with acid.” Clothes and other materials found too contaminated were sunk into the ocean a mile below the surface, because there was literally “no other way to keep them permanently away from human beings.”

In the article, Warren concluded that atomic weapons can never be prepared for by anyone involved, and that “no defense would have been effective. The only defense against atomic bombs still lies outside the scope of science. It is the prevention of atomic war.”

Warren left his position in 1946, becoming the Chief of the Medical Section of the Atomic Energy Commission, which is a civilian agency that succeeded the Manhattan Project; and later he was awarded the Army Distinguished Service Medal and the Legion of Merit for his contributions to radioactive and atomic weapons safety.

In 1947, Warren was once again at the helm of a brand new medical university, this time UCLA, which had been voted on to establish a medical school for Southern California. He was appointed as the school’s first dean. In 1951 the first students, 28 in total, were enrolled, and there were 15 faculty members. By 1955, when the class graduated, there were 43 faculty members. The UCLA Medical Center officially opened in 1955, and Warren oversaw many milestones and achievements while there, including the addition of schools for Dentistry, Nursing, and Public Health.

Good,, Bad, and Trans Fats and the Health Risk They Pose

What many don’t realise is that fats are essential for good health. The brain, for instance, is contains fat, but it is the good one and not that which can kill you. As people age they become more susceptible to weight gain and the large stomachs seen in many. The fat around their middle is from bad fats that usually come from things like sugar and trans fats.

Alcohol is the same as sugar in its molecular component. In other words, sugar breaks down into the same structure as alcohol and this is why beer drinkers end up with what is described as a ‘beer gut’. But that is not trans fat but the product of a normal digestive function whereby the ‘sugar’ overloads the liver and turns into fat.

In that case one may end up with a fatty liver and possibly pancreas leading to cancer of the organs. It also leads to diabetes and loss of limbs, eye-sight, and heart disease, among other things.

Then there are the trans-fats and these are normal fats that have undergone transformation due to heat. They take on extra molecules of hydrogen during the process and that makes them virtually indigestible by the liver so that they are laid around the vital organs.

The worst practice comes from super heated and oft heated oils. They are found in commercial ovens where deep fried fish and vegetables are produced. They are the in many of the snack foods people are addicted to while the warning that should accompany them is that they can lead to diseases, as described above, and even death.

Get More Reliable Cost Air Ambulance Service In Patna With Medical Team By Global

The demand for hiring an emergency air moving service in Patna is increasing day by day because many people are familiar with the world, in Patna, more reliable and affordable cost of the air Ambulate as well as all other small and big cities Very seriously offer to move ill patients from one end to the other end at a very quick time. We provide commercial and charter air Rehabilitation service in Patna with all types of basic and advanced medical facilities as per the patient’s demand which is very cheap for all the class families. We provide Emergency Air Ambulance 24 hours a day with a long and experienced trained and well-trained MD doctors and special paramedical technicians for proper care and health care at transportation times.

The company has managed to make its Professional services unique in the highly competitive domestic and international market by distributing the highest level commitment. The company started air medieval services from Patna to Delhi from Bangalore to Mumbai and in a short time managed to expand its operations around the world.

This Company offers emergency air ambulance services, ranging from beds to basic and advanced medical facilities as well as other cities like Delhi, Bangalore, Mumbai, all basic and advanced medical facilities are available for severely ill patient transport., So that you can get better and comfortable treatment. We do not charge any type of emergency patient for any type of advanced and high-quality medical facilities at the time of transportation.

Discussion on Cell Therapy From The Point of Standardization, Scale, and Industrialization

What is cell therapy?
Cell therapy refers to the transplantation or input of normal or bioengineered human cells into a patient’s body and newly-imported cells can replace damaged cells or involve a stronger immune killing function, so as to achieve the purpose of treating diseases. Cell therapy has shown higher application value in the treatment of cancer, hematological diseases, cardiovascular diseases, diabetes, Alzheimer’s disease etc. In general, cell therapy includes tumor cell immunotherapy and stem cell therapy. There are two cell sources for cell therapy, one from the patient itself and the other from the allogeneic tissue.

The Defects of Cell Therapy
The cell is the most basic unit that contributes to a living organism, however, it does not mean that everyone shares the same cells. On the contrary, there is a huge difference in each individual which can be compared to human-to-human differences, that is, two identical people never exist. The huge difference between cells and cell preparations is the biggest drawback of cell therapy. In this post, we will discuss several issues that need attention in the current stage of cell therapy.

Difficulties in the Standardization of Cell Therapy
Cancer cell immunotherapy cannot be standardized from the stage of raw material acquisition. The cell treatment materiasl for each paitient are their own blood leukocytes. The condition and physical condition of each patient are different, and the collected white blood cell growth quantity and kill activity are not uniform and cannot be standardized. As it is impossible to standardize raw materials, preparation processes, and product specifications, it cannot be standardized, industrialized, and scaled up. Each tumor cell immunotherapy laboratory meets the GMP level with the hardware environment, and it can be more like a cell preparation workshop. Researchers ranged in number from a few to a dozen and could not really meet the standards of division of labor of industrialized pharmaceutical companies. Taking stem cell therapy that using umbilical cord mesenchymal stem cells as an example, which raw material is an umbilical cord, and one umbilical cord-produced cell can be utilized by many paitients. The standardization path is more advanced than the immunotherapy of tumor cells, and the raw materials can be standardized to some extent.

Difficulties in The Scale of Cell Therapy Industry
At present, the production mode of the cell therapy industry mainly depends on technicians. In the 10,000-grade clean laboratory, the cells are operated in class 100 clean bench, cultured in a carbon dioxide incubator, centrifuged in a centrifuge, observed through an inverted microscope, and the drug reagents are stored in a medicine refrigerator. All of these devices are operated by independent biological laboratories of the individual and being linked together through the operations of scientists. This type of production model is small in scale and similar to workshop-type production. Although there are some large scales, the essence is a collection of many small workshops. Due to the small scale, the instruments used are laboratory instruments and many of the reagents used are scientific reagents, which will lead to the issue of low efficiency but high cost.

Autologous or Allogeneic
There are two kinds of cell sources for cell therapy, one from the patients and the other from the allogeneic tissue. Autologous cell therapy cannot be standardized from the raw material acquisition stage, and it are only applied to the patient itself, the essence is essentially medical technology. The prevalence of autologous cell therapy as a medical technology is mainly due to the scale of the predicament. Allogeneic therapy, the cells derived from allogeneic. Taking tumor cell immunotherapy as an example, the cell source may be from cord blood, and the larger-scale cell source may be a filter plate for leukocyte filtration at the blood bank. Taking umbilical cord mesenchymal stem as an example, the cell source is the umbilical cord, and one umbilical cord-producing cell can be used by more than one person. If scale can be cultivated, although the quality standards cannot be quantified well, the scaled products themselves have a certain degree of standardized properties.

The cell industry, as an industry, is not the path to the advancement of cell-based therapeutics. If the advanced technology cannot be mass-produced on a large scale, it can only stay in the laboratory and become the object of research for scientists, never have achance to become a drug into the majority of patients. For allogeneic cell therapy that using allogeneic cells as raw materials, the standardized properties of the scaled products can be realized if large-scale cultures are prepared, then scale and standardization can promote each other. The current progress in standardization of cells is not easy, but the progress in scale should be relatively easy to achieve.

Natural cytokine supernatants with more standardized and standardized properties
Cytokines are a class of small molecule proteins with broad biological activity synthesized and secreted by immune cells (such as monocytes, macrophages, T cells, B cells, NK cells, etc.) and certain non-immune cells (endothelial cells, epidermal cells, fibroblasts, etc.) Immune responses are regulated by binding to the respective receptors to regulate cell growth, differentiation and effects. Cytokines (CK) are low-molecular-weight soluble proteins that are produced by various types of cells induced by immunogens, mitogens, or other stimulants. They have the ability to regulate innate immunity [1] and adaptive immunity [2], hematopoiesis, cell growth, and damage tissue repair and other functions.

Cytokines can be divided into interleukins, interferons, tumor necrosis factor superfamily, colony stimulating factors, chemokines, growth factors etc. Cytokines form a very complex cytokine regulatory network in the body and participate in many important physiological functions of the human body. Where stem cells and immune cells cannot reach the body, cytokines can easily reach target tissue sites because of their small size.

In recent years, recombinant gene cytokines have made remarkable achievements in clinical applications as a novel biological response modifier. A large part of the effects of stem cell therapy and immune therapy arises from the action of cytokines secreted in the body. The stem cells and immune cells in the body are introduced back into the body to secrete a variety of natural structural cytokines. Although the amount of these cytokines is relatively small, they are synergistic and act directly on the cytokine network in the body because of their high natural structure activity, lack of antigenicity but diversity. Because of the standardization, standardization, industrialization, and scale of natural compound cytokines, it is more cost-effective than cell therapy, allowing more patients in need to enjoy cell-like therapeutic effects.

Although natural complex cytokines can largely replace cell therapy, but there are still conditions that require the presence of cells to exert a therapeutic effect. We hope that cell therapy can break the current situation, become high efficiency and low cost with large scale, more standardization, and then be applied to more disease treatments.

Cancer Immunotherapy Use on Cancer Patients

Recent advances in treating cancer patients have resulted in the development of biological therapies that can prove to be a promising alternative to conventional cancer therapies. Immunotherapy harnesses the body’s immune system to identify and fight effectively against cancer cells.

Immunotherapy works by attacking the growth of cancer cells or stimulating the immune system to kill cancer cells. Contradictory to the standard cancer treatment regimes such as chemotherapy, radiation therapy, which act on both normal and cancerous cells, immuno-therapeutic treatments are highly specific. A wide range of cancer immuno-therapy approaches exists such as immune checkpoint blockers, cancer vaccines, immune-modulators, monoclonal antibodies and cell based immuno-therapies have demonstrated to be effective against cancer patients.

The most commonly targeted form of cancer chemotherapy is the use of monoclonal antibodies as they can be tailor-made in the laboratory. They have unique antigen specificity thereby allowing themselves to attach to specific epitopes on cancer cells. This flags the cancer cells and makes it more visible to the immune system so that it can find and destroy those cells. Currently, most of the monoclonal antibodies are undergoing phase 3 clinical trials or awaiting FDA review process. Unlike monoclonal antibodies, non-specific immuno-therapy approaches such as administration of immuno-modulatory cytokines are also being used to treat melanoma. Cytokines are hormones that are endogenously produced by the body to enhance or suppress T-cell response against cancer cells. IFN-α and IL-2 are most commonly characterized cytokines used in cancer immuno-therapy.

The primary cell-based immuno-therapy strategy which is successful these days is the use of T-cell therapy, wherein cancer T cells removed from blood are modified with chimeric antigen receptor (CAR) and is then infused back into the patients to treat metastatic cancer. Another form of cell-based immuno-therapy used is tumor-infiltrating lymphocytes (TIL) therapy, wherein TIL is surgically removed from tumor tissue and is considerably increased in the laboratory by adding cytokines to it and is then re-infused back into the patient.

A promising treatment that has emerged in recent times for treatment of melanoma is the use of immune checkpoint inhibitors. They act by inhibiting the checkpoint receptors on T cells that act as brakes to the immune system thereby mediating anti-tumor responses. Some of the commonly used antibody inhibitors that have been commercialized are PD-1, PDL-1, and CTLA-4. Another more focused approach to cancer immuno-therapy is the use of vaccines to encourage the immune system to generate antibodies that can target tumor specific antigens, thereby eradicating cancerous cells. Cancer vaccines include peptide-based, dendritic cell-based, tumor cell-based and DNA cell based. Cancer vaccines can be broadly classified as preventive or therapeutic. Preventive vaccines are commercially available for against cervical and liver cancer causing viruses such as human Papillomavirus and Hepatitis B virus, respectively.

However, in spite of these advances, limitation such as tumor heterogeneity, unpredictable efficacy and identification of potential markers still exist in the field of cancer immuno-therapy. Therefore, new more targeted cancer immuno-therapies and preventive strategies are being developed and tested, which will deliver novel efficacious therapy against relapsed or refractory cancer patients.

Struggling With Antibiotic Resistance

I never saw it coming. The process started with a small, but painful sensation right in the middle of my right butt-cheek. A very annoying problem because I am a writer squirming around as I try to fill up empty screens with words.

At first, I downplayed it as just some stupid little irritation that would go away as soon as it came. Being a diabetic for about 25 years now I am prone to inflammations and infections. This was just another in a long succession of intermittent, annoying, health problems.

At the onset, the thought never occurred that it might be an infection. I had not had any accident, no cuts, abrasions or scrapes so that did not pop up as the culprit. That is until it persisted and grew into an open sore. The pain level also rose dramatically.

I went to the doctor. He did not think it was serious. He wrote a prescription for a mild antibiotic and a cream. I left the office confident that the problem was in hand. Back home I took a pill, applied the cream and applied a bandage.

By that point sitting at my computer and performing my daily writing ritual was growing into a serious challenge. The pain was so intense that I had to force myself not to move at all. That worked for a while. I took the full antibiotic course and got into the habit of cleaning and dressing the open wound three times a day.

The process began last November. As I came to the end of the bottle of pills I was hit by a wave of disappointment and confusion. I had to face the fact that the infection had gotten worse, not better. Had the doctor misdiagnosed it? Had he given me the wrong antibiotic? Worse, did I have some rare new infection?

I went back to his office in a far more worried state than I was during my first visit. He admitted he was puzzled but brushed that aside. I got a new prescription for a stronger antibiotic that was going to require four consecutive injections.

Once again I returned home feeling a bit numb but optimistic that this stronger injectible antibiotic would do the trick. I got the injections and waited for the medication to build up in my system and wipe out the infection. I waited and waited. The situation did not get better it got even worse.

By then I could not sit and also had a hard time walking. The pain was constant even when I was trying to write while lying down. This time when I returned to the doctor’s office he told me to go to the emergency room. He would not try another antibiotic. In fact, he seemed at a loss.

Instead, I went to a clinic. The doctor there did prescribe another antibiotic, took a culture for the lab and had nurses scrub the wound. It just kept growing as if the antibiotic cream was a placebo and the injections had been nothing but water.

At that point, I had added symptoms including chronic fatigue and the first signs of depression. These two are features of a diabetic’s life and I knew what they were as soon as they arose. My immune system was beaten down and using whatever energy it could get from whatever source was available.

I did not get my hopes up during the third two-week course of the latest antibiotic. In fact, I was on pins and needles the whole time. When I finished I was not surprised that it too had failed at its job. Still, it never occurred to me that I might be antibiotic resistant.

By that point, I began to consider the possibility that my 71-year old body was running out of gas. My energy level was so low, and pain level so high that I could not write. I could only walk the short distance to the corner store to ship and my mood was buried in the pits.

When I returned to the doctor’s office he did not seem too surprised by the fact his prescription had failed. He put the lab report up on the lightbox and pointed to it. “I am afraid the results show you are resistant to every type of antibiotic we have.”

I simply could not wrap my mind around his statement. I had never thought that I had overused antibiotics to the point my immune system built up a total tolerance. Then again, nobody ever tells you where that line is.

In fact, I had taken at least one course each of the 3 previous years to cure sinus infections. I left the office completely confused and with no idea of what to do next. The doctor suggested that I schedule an operation to remove the infected area. My thought was that hospitals are great places to contract infections. I was not eager to take that option especially when it would mean I could not sit at the computer and work for a much longer period of time.

Believe it or not, that whole process went on for four months and I still had the infection. I decided to tough it out and see if my body would mobilize and get rid of it. Then I had an impulse to try one more doctor, a female who I had seen before and was impressed by.

She gave me a spray that the other doctors never mentioned, Microdacyn. This spray is a biologically active treatment for the treatment of acute and chronic wounds that are difficult to heal. I applied and applied it every day and started seeing improvement much to my relief.

My status now is guarded and uncertain. I do now I cannot afford one more sinus infection. I did discover one effective treatment, Phage Therapy. However, that is only available in Eastern Europe. I advise a very conservative approach when it comes to taking antibiotics, only do so when it is truly necessary.

Analysis to Next Generation Sequencing Technology

With the development of science, traditional Sanger sequencing has failed to meet new requirements of low cost, high throughput and fast in speed.

Recent years, with the discovery and promotion of second-generation sequencing technology, the gene sequencing speed has increased greatly while achieving a substantial decline in costs, making large-scale application of genome sequencing possible. Now, the cost of personal whole genome sequencing is about 5,000$, and is expected to decreased to less than $ 1,000 in the next few years.

The rapid development of sequencing technology will promote the massive accumulation of DNA sequencing data, accompanied by the accumulation of the corresponding individual diseases, signs and other data at the same time. When we accumulate enough data, how to understand these data will be critical. On the micro level, generations of molecular biologists’ studying the effects of apparent biological traits genes exert on utilizing technologies like gene knockout have made breakthroughs in many crucial aspects. On the macro level, statistics and other data analysis techniques are introduced to study the relationship between gene sequences and biological phenotype. The accumulation of basic scientific research gradually brings breakthroughs in clinical applications.

There are now two types of clinical applications mainly, one aims at disease screening of ordinary people. It infers people’s future risks of getting cancer by measuring the known genes associated with a disease loci. The other aims at the diagnosis cancer and other deadly diseases. It finds in a series of drugs or plans the most effective one for certain patients by testing the loci of certain genes.

Data from BBC research shows that total global gene sequencing market increased from $ 7.941million in 2007 to $ 4.5 billion in 2013, and will reach $ 11.7 billion in the year of 2018 with the CAGR up to 21.2%.

Currently, the market of de novo sequence platform is mainly taken by several major manufacturers, including the Illumina, Ion Torrent / Life Technologies (was the acquisition of Thermo Fisher in 2014), 454 Life Sciences / Roche, etc.

Under such a circumstance, the next generation sequencing technology (second-generation sequencing) appears. As an emerging industry, the next-generation sequencing technology can be applied in clinical testing like antibody discovery, health industry, industrial and agricultural use of gene-oriented study as well as scientific research and development.